Good Morning, It's Tuesday January 24th, 2012,...
(more)
Good Morning, It's Tuesday January 24th, 2012, I'm Christina Collins with CRWENewswire Stocks In Action
BioLineRx Limited - symbol BLRX - reported that it has signed a worldwide, exclusive license agreement with Genoscience, to develop and commercialize BL-8020, an orally available treatment for Hepatitis C.
(less)
|
|
